Effect of resveratrol on scopolamine-induced cognitive impairment in mice

被引:0
作者
Gupta, Rachna [1 ,2 ]
Gupta, Lalit K. [3 ,4 ]
Mediratta, Pramod K. [1 ,2 ]
Bhattacharya, Swapan K. [1 ,2 ]
机构
[1] Univ Coll Med Sci, Dept Pharmacol, New Delhi 110095, India
[2] GTB Hosp, New Delhi 110095, India
[3] Lady Hardinge Med Coll & Hosp, Dept Pharmacol, New Delhi 110001, India
[4] Smt SK Hosp, New Delhi 110001, India
关键词
resveratrol; scopolamine; cognition; step down latency; transfer latency; escape latency; CANCER CHEMOPREVENTIVE ACTIVITY; RED WINE; MEMORY; PROTECTS; RAT; BIOAVAILABILITY; NEUROTOXICITY; POTENTIATION; INVOLVEMENT; METABOLISM;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Resveratrol (3,4',5-trihydroxystilbene) is a naturally occurring compound found in grapes, wine, peanuts and cranberries. Recently, in vitro and cell culture studies have reported beneficial effects of resveratrol in the neurodegenerative process in Alzheimer's disease (AD). However, in vivo effect of resveratrol in models of learning and memory is not yet evaluated. The present study was performed to examine the effect of resveratrol on cognitive impairment induced by scopolamine, a muscarinic antagonist, in mice. Methods: Scopolamine was administered in a dose of 1 mg/kg intraperitoneally (ip). Cognitive functions were assessed using transfer latency (TL) on elevated plus maze, step-down latency (SDL) on a passive avoidance apparatus and escape latency (EL) in Morris water maze test. Results: Scopolamine produced significant prolongation of TL, reduction in SDL as well as EL showing cognitive impairment in mice. Pre-treatment with resveratrol (10 mg/kg and 20 mg/kg, ip) for 21 days showed no difference in TL, SDL and EL. Conclusion: Resveratrol treatment does not reverse scopolamine-induced deficit in cognitive functions in mice.
引用
收藏
页码:438 / 444
页数:7
相关论文
共 39 条
[1]   RETENTION OF A PASSIVE AVOIDANCE RESPONSE AS A FUNCTION OF INTENSITY AND DURATION OF ELECTRIC SHOCK [J].
ADER, R ;
MOLEMAN, P ;
WEIJNEN, JAW .
PSYCHONOMIC SCIENCE, 1972, 26 (03) :125-&
[2]   Effects of the uncompetitive NMDA receptor antagonist memantine on hippocampal long-term potentiation, short-term exploratory modulation and spatial memory in awake, freely moving rats [J].
Barnes, CA ;
Danysz, W ;
Parsons, CG .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1996, 8 (03) :565-571
[3]   Therapeutic potential of resveratrol:: the in vivo evidence [J].
Baur, Joseph A. ;
Sinclair, David A. .
NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (06) :493-506
[4]  
BERTELLI AAE, 1995, INT J TISSUE REACT, V17, P1
[5]  
Blokland A., 2005, Scopolamine Rev, V1, P1
[6]  
Das DK, 1999, DRUG EXP CLIN RES, V25, P115
[7]  
Gescher AJ, 2003, CANCER EPIDEM BIOMAR, V12, P953
[8]   Cholinergic foundations of Alzheimer's disease therapy [J].
Giacobini, E .
JOURNAL OF PHYSIOLOGY-PARIS, 1998, 92 (3-4) :283-287
[9]   Cholinesterases: New roles in brain function and in Alzheimer's disease [J].
Giacobini, E .
NEUROCHEMICAL RESEARCH, 2003, 28 (3-4) :515-522
[10]   Absorption of three wine-related polyphenols in three different matrices by healthy subjects [J].
Goldberg, DA ;
Yan, J ;
Soleas, GJ .
CLINICAL BIOCHEMISTRY, 2003, 36 (01) :79-87